SFW Capital bets on stability testing for vaccines and drug development, LightBay's senior members get back into women's health It’s hump day, readers. Here’s what’s happening today:
SFW Capital has made a controlling investment in Caron Products & Services, whose laboratory equipment is used in stability testing for everything from complex vaccines (including covid-19 vaccines) to more commonly used pharmaceutical products.
“Whether it’s your Tylenol or cell and gene therapy – each one of those products needs to have a shelf life [so] that they are actually going to be active when they are used. How do you find out? You find out by using one of Caron’s products,” Ahmad Sheikh, partner at Rye, New York’s SFW, told PE Hub in an interview. Read more on PE Hub.
New(ish) shop to watch: LightBay Capital may be new to the scene, but the seasoned investors leading the Los Angeles firm are finding opportunity to deploy capital in segments proven successful in a prior lifetime. The more than three-year-old private equity firm – founded by two former partners of Ares Management private equity – closed an investment in Femwell Group Health, a physician-led women’s healthcare business based in Miami, a source with knowledge of the deal told PE Hub. Check out my full report on PE Hub.
That's it for today. As always, hit me up with any comments, tips or just to say hello!
Read the full wire commentary on PE Hub.
We hope you’re enjoying the new streamlined PE Hub Wire. For a more detailed version, we have launched a new premium version for our paying PE Hub subscribers that is ad-free and includes full editorial commentary and descriptions with each story. For more information about the Wire Premium, reach out to subscriptions@peimedia.com.
That's it for today. Have a great week, everyone, and as always, feel free to shoot me an email with tips, feedback or just about anything at Karishma.v@peimedia.com.
Note to Readers: It's that time of year ... for the 21st time, the editors of PE Hub and Buyouts honor exceptional buyouts with our Deal of the Year Awards. Winners are chosen in seven categories: Deal of the Year, Large-Market Deal of the Year, Middle-Market Deal of the Year, Small-Market Deal of the Year, Turnaround of the Year, International Deal of the Year, and Secondaries Deal of the Year. Go here for more information and to read about rules and methodology. Also check out past winners. Last year, New Mountain took the crown with its exit of Equian. If you have additional questions, email Private Equity Editor Chris Witkowsky at cwitkowsky@buyoutsinsider.com.
Also of note (may require subscriptions) PE coffers: Ares Management is targeting $4 billion for its second junior capital direct lending fund, with the latest commitment coming from School Employees’ Retirement System of Ohio. For more detail, check out Buyouts full report. Appointment: President-elect Joe Biden is expected to select former Goldman Sachs executive Gary Gensler to head the SEC, people familiar with the decision told the Wall Street Journal. Gensler during the Obama administration led the overhaul of derivatives markets mandated by the Dodd-Frank Act. Read more on WSJ. Up for sale: Golden Gate Capital is exploring a sale of its Mavis Express Tire Services business that could value the company at as much as $6 billion, people familiar with the matter told Bloomberg. Read more here. Movin' onward: Tom Lister, co-managing partner at Permira, has stepped away from his role, Private Equity International has learned. Lister had co-managed leadership at the London-based firm since 2008. Read more on PEI.
They said it “We’re focused on the scientists and their workflow – and how we can make their lives easier.”
Ahmad Sheikh, partner at SFW Capital, told PE Hub, speaking to the firm's investment in lab equipment company Caron Products & Services
Today's letter was prepared by Sarah Pringle Subscribe now to get full, unlimited access to all PE Hub content, including every PE Hub Wire article. Please visit Buyouts for the latest insight into LP activity and Venture Capital Journal for comprehensive coverage and analysis of what’s happening in VC. To update your PE Hub email preferences, or to unsubscribe, click here. |